Biotech: Baiaotai\'s announcement on voluntary disclosure of the company\'s approval as a high-tech enterprise
Baiaotai\'s Announcement on Voluntary Disclosure of the Company\'s Renewal as a High-tech Enterprise
Biotech: Biotech\'s announcement on signing a licensing and commercialization agreement with Intas Pharmaceuticals Ltd for BAT2506 (golimumab) injection
Biotech: Biotech voluntarily disclosed the notice of approval for clinical trials of injectable BAT1006 combined with trastuzumab and chemotherapy to treat breast cancer
Biotech\'s announcement on signing a licensing and commercialization agreement with Intas Pharmaceuticals Ltd for BAT2506 (golimumab) injection
Biotech voluntarily disclosed the notice of approval for clinical trials of injectable BAT1006 combined with trastuzumab and chemotherapy to treat breast cancer
Biotech\'s announcement on acceptance of the marketing license application for scuchiumab injection (BAT2306)
Biotech voluntarily disclosed an announcement that the marketing license application for BAT2506 (golimumab) injection was accepted by the European EMA
Announcement of Resolutions of the 17th Meeting of the 2nd Board of Supervisors of Biotech
Biotech: Biotech voluntarily discloses an announcement regarding the signing of licensing and production, supply and commercialization agreements with Steincares for BAT2306 (scuchiumab) injection
Biotech: Announcement of Resolutions of the 20th Meeting of the 2nd Board of Directors of Biotech
Announcement of Resolutions of the 20th Meeting of the 2nd Board of Directors of Biotech
Biotech voluntarily disclosed an announcement regarding the signing of licensing and production, supply and commercialization agreements with SteinCares for BAT2306 (scuchiumab) injection
Biotech Investor Relations Activity Record Form (2024 Third Quarter Results Briefing)
Biotech\'s announcement on holding a results briefing for the third quarter of 2024
Biotech: Biotech on Gedeon Richter Plc. (Jiri Pharmaceuticals) Announcement on the signing of licensing and production, supply and commercialization agreements for BAT2206 (usinumab) injections
Biotech Investor Relations Activity Record Form (2024 Semi-Annual Science and Technology Innovation Board Pharmaceutical and Biological Products Group Performance Briefing)
Biotech Investor Activity Record Form (2024 Investor Online Group Reception Day Event in Guangdong Province)
Baiaotai\'s announcement on participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products
Baiaotai\'s announcement on participating in the 2024 Investor Online Group Reception Day in Guangdong